Authors: Oosterga, M Voors, AA Pinto, YM Buikema, H Grandjean, JG Kingma, JH Crijns, JHGM van Gilst, WH

Citation: M. Oosterga et al., Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS study), AM J CARD, 87(5), 2001, pp. 542-546

Authors: Oosterga, M Voors, AA Buikema, H Pinto, YM Haber, HE Ebels, T Morshuis, WJ Kingma, JH Crijns, HJGM van Gilst, WH

Citation: M. Oosterga et al., Angiotensin II formation in human vasculature after chronic ACE inhibition: A prospective, randomized, placebo-controlled study, CARDIO DRUG, 14(1), 2000, pp. 55-60

Authors: de Kam, PJ Voors, AA van den Berg, MP van Veldhuisen, DJ Brouwer, J Crijns, HJGM Borghi, C Ambrosioni, E Hochman, JS LeJemtel, TH Kingma, JH Sutton, MS van Gilst, WH

Citation: Pj. De Kam et al., Effect of very early angiotensin-converting enzyme inhibition on left ventricular dilation after myocardial infarction in patients receiving thrombolysis - Results of a meta-analysis of 845 patients, J AM COL C, 36(7), 2000, pp. 2047-2053

Authors: van Lennep, JER Zwinderman, AH van Lennep, HWOR Westerveld, HE Plokker, HWM Voors, AA Bruschke, AVG van der Wall, EE

Citation: Jer. Van Lennep et al., Gender differences in diagnosis and treatment of coronary artery disease from 1981 to 1997 - No evidence for the Yentl syndrome, EUR HEART J, 21(11), 2000, pp. 911-918

Authors: Van Veldhuisen, DJ Voors, AA

Citation: Dj. Van Veldhuisen et Aa. Voors, Blockade of the renin angiotensin system in heart failure: the potential place of angiotensin II receptor blockers, EUR HEART J, 21(1), 2000, pp. 14-16

Authors: van Geel, PP Pinto, YM Voors, AA Buikema, H Oosterga, M Crijns, HJGM van Gilst, WH

Citation: Pp. Van Geel et al., Angiotensin II type 1 receptor A1166C gene polymorphism is associated withan increased response to angiotensin II in human arteries, HYPERTENSIO, 35(3), 2000, pp. 717-721